The Netherlands has become the latest country to suspend use of the Oxford-AstraZeneca coronavirus vaccine over concerns about possible side effects.
The Dutch government said the move, which will last until at least 29 March, was a precaution.
The Republic of Ireland earlier made a similar decision over reports of blood clotting events in adults in Norway.
But the World Health Organization (WHO) says there is no link between the jab and an increased risk of developing a clot.
The European Medicines Agency (EMA) - which is currently carrying out a review into incidents of blood clots - says the vaccine's benefits continue to outweigh its risks.
Denmark, Norway, Bulgaria, Iceland and Thailand have already halted their use of the AstraZeneca vaccine.
What measures did the Dutch government take?
In a statement, the Dutch government said it was acting out of precaution following reports from Denmark and Norway of possible serious side effects.
"We can't allow any doubts about the vaccine," Dutch Health Minister Hugo de Jonge said.
"We have to make sure everything is right, so it is wise to pause for now."
Sunday's decision will now cause delays in the Dutch vaccination programme.
The authorities had pre-ordered 12 million doses of AstraZeneca, with nearly 300,000 jabs scheduled in the next two weeks.
What did AstraZeneca say?
In a statement, AstraZeneca said there was no evidence of an increased risk of clotting due to the vaccine.
It said that across the EU and United Kingdom there had been 15 events of deep-vein thrombosis (DVT) and 22 events of pulmonary embolism reported among those vaccinated.
"Around 17 million people in the EU and UK have now received our vaccine, and the number of cases of blood clots reported in this group is lower than the hundreds of cases that would be expected among the general population," said Ann Taylor, the firm's chief medical officer.
"The nature of the pandemic has led to increased attention in individual cases and we are going beyond the standard practices for safety monitoring of licensed medicines in reporting vaccine events, to ensure public safety."
Latest Stories
-
Contributors own SSNIT, they must decide who becomes its Director-General – Austin Gamey
23 mins -
Move away from theory-based learning towards practical learning approaches – AUCC President to students
32 mins -
Haaland scores as Manchester City beat Nottingham Forest
2 hours -
Villas-Boas elected Porto president
2 hours -
Situation on frontline has worsened, Ukraine army chief says
2 hours -
US doctor describes witnessing starvation in northern Gaza
2 hours -
CAFCC: RS Berkane make final after USM Alger refused to play 2nd leg over Moroccans’ jersey
2 hours -
Elon Musk in China to discuss enabling full self driving
2 hours -
PSG clinch Ligue 1 title after Lyon’s win over Monaco
4 hours -
Guinness Ghana sets the pace at Ghana Beverage Awards with six awards
5 hours -
Burkina Faso suspends BBC, VOA radio broadcasts over killings coverage
5 hours -
Nicole Kidman honoured with AFI Life Achievement Award
5 hours -
Brassier scores winner for Brest as they edge Rennes to secure European football
5 hours -
Akufo-Addo jabs Ejisu independent candidate; rubbishes allegations to rig by-election
6 hours -
‘What are the real causes of the erratic power outages?’ GUTA asks ECG
6 hours